Notice: This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisCompetitorsEarningsInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for LogicBio Therapeutics (NASDAQ:LOGC)CurrentInstitutional OwnershipPercentage46.05%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$251.74KNumber ofInstitutional Sellers(last 12 months)0 Get LOGC Insider Trade Alerts Want to know when executives and insiders are buying or selling LogicBio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LOGC Institutional Buying and Selling by Quarter Ad DTII've got news for you… Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman LogicBio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC46,190$252K0.0%N/A0.176% 11/4/2022 Prudential Financial Inc.98,600$27K0.0%+54.1%0.299% 4/28/2022 Harbor Capital Advisors Inc.226,731$154K0.1%-19.8%0.688% 2/15/2022 Samlyn Capital LLC1,511,417$3.49M0.0%+2.5%4.586% 2/14/2022 Eversept Partners LP291,101$672K0.0%-16.8%0.883% 2/14/2022 Blair William & Co. IL21,950$51K0.0%N/A0.067% Get the Latest News and Ratings for LOGC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LogicBio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/4/2022 Harbor Capital Advisors Inc.282,578$653K0.2%N/A0.857% 2/2/2022 Sanders Morris Harris LLC15,000$35K0.0%-57.1%0.046% 1/26/2022 Independence Bank of Kentucky12,875$30K0.0%N/A0.039% 11/16/2021 Verition Fund Management LLC113,532$520K0.0%-45.4%0.352% 11/15/2021 Pura Vida Investments LLC245,492$1.12M0.0%-1.5%0.761% 11/15/2021 Sphera Funds Management LTD.24,042$110K0.0%N/A0.075% 11/15/2021 Eversept Partners LP349,919$1.60M0.1%N/A1.085% 11/9/2021BlackRock Inc.215,736$988K0.0%-2.4%0.669% 11/9/2021 Platinum Investment Management Ltd.320,273$1.47M0.0%N/A0.993% 10/29/2021Commonwealth Equity Services LLC12,836$58K0.0%N/A0.040% 10/13/2021 Sanders Morris Harris LLC35,000$160K0.0%+133.3%0.109% 8/25/2021 Marshall Wace LLP40,568$180K0.0%N/A0.126% 8/17/2021 Walleye Capital LLC23,877$106K0.0%N/A0.074% 8/17/2021 Walleye Trading LLC12,411$55K0.0%N/A0.038% 8/17/2021 Bridgeway Capital Management LLC76,500$340K0.0%-58.2%0.237% 8/16/2021 State Street Corp24,807$110K0.0%-89.4%0.077% 8/16/2021Tibra Equities Europe Ltd76,500$340K0.1%N/A0.237% 8/16/2021 Goldman Sachs Group Inc.55,030$244K0.0%+59.0%0.171% 8/16/2021 Marshall Wace LLP40,568$180K0.0%N/A0.126% 8/13/2021 Renaissance Technologies LLC96,500$428K0.0%N/A0.299% 8/13/2021 Northern Trust Corp29,636$131K0.0%-83.3%0.092% 8/13/2021 Geode Capital Management LLC132,121$586K0.0%-42.4%0.410% 8/13/2021 Vanguard Group Inc.715,782$3.18M0.0%-10.5%2.220% 8/12/2021 Trexquant Investment LP46,229$205K0.0%+190.0%0.143% 8/12/2021 Dimensional Fund Advisors LP28,170$125K0.0%N/A0.088% 8/12/2021 JPMorgan Chase & Co.57,286$254K0.0%-76.3%0.178% 8/12/2021Ergoteles LLC66,783$297K0.0%N/A0.208% 8/11/2021 Bank of New York Mellon Corp10,930$49K0.0%-79.8%0.034% 8/11/2021 Susquehanna International Group LLP28,384$126K0.0%N/A0.088% 8/5/2021 Texas Yale Capital Corp.20,000$89K0.0%+100.0%0.062% 7/31/2021 Sanders Morris Harris LLC15,000$67K0.0%N/A0.047% 5/19/2021Virtu Financial LLC23,721$173K0.0%N/A0.074% 5/19/2021 Squarepoint Ops LLC12,954$94K0.0%N/A0.040% 5/18/2021 Verition Fund Management LLC226,965$1.65M0.0%-1.2%0.706% Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link.5/17/2021 Samlyn Capital LLC1,399,844$10.19M0.1%-1.2%4.353% 5/17/2021 EcoR1 Capital LLC688,700$5.01M0.2%-11.1%2.141% 5/17/2021 Nuveen Asset Management LLC34,958$254K0.0%+11.7%0.109% 5/17/2021 Goldman Sachs Group Inc.34,607$252K0.0%+14.3%0.108% 5/13/2021 Trexquant Investment LP15,941$116K0.0%N/A0.050% 5/13/2021 Barclays PLC28,567$208K0.0%+41.8%0.089% 5/12/2021 Northern Trust Corp177,029$1.29M0.0%-2.8%0.550% 5/12/2021 Geode Capital Management LLC229,415$1.67M0.0%+11.8%0.713% 5/12/2021 Pura Vida Investments LLC253,102$1.84M0.1%+1.2%0.787% 5/12/2021 Texas Yale Capital Corp.10,000$73K0.0%N/A0.031% 5/12/2021 JPMorgan Chase & Co.241,799$1.76M0.0%-15.5%0.752% 5/10/2021 GSA Capital Partners LLP110,913$807K0.1%N/A0.345% 5/7/2021BlackRock Inc.984,011$7.16M0.0%+8.9%3.060% 2/25/2021 Hsbc Holdings PLC15,396$118K0.0%N/A0.048% 2/19/2021 JPMorgan Chase & Co.286,294$2.18M0.0%-6.9%0.901% 2/18/2021 Verition Fund Management LLC229,834$1.75M0.0%N/A0.723% 2/16/2021 Orbimed Advisors LLC8,466,783$64.60M0.6%+30.9%26.637% 2/16/2021 Pura Vida Investments LLC250,000$1.91M0.1%N/A0.787% 2/16/2021 Baker BROS. Advisors LP451,478$3.45M0.0%N/A1.420% 2/16/2021 Nuveen Asset Management LLC31,290$239K0.0%+5.6%0.098% 2/16/2021 Charles Schwab Investment Management Inc.34,198$261K0.0%+31.9%0.108% 2/13/2021 American International Group Inc.9,533$73K0.0%+30.7%0.030% 2/12/2021 The Manufacturers Life Insurance Company11,781$90K0.0%N/A0.037% 2/11/2021 Northern Trust Corp182,136$1.39M0.0%+34.8%0.573% 2/11/2021 Barclays PLC20,150$154K0.0%+137.2%0.063% 2/11/2021 Citigroup Inc.3,339$25K0.0%+277.3%0.011% 2/10/2021 Rhumbline Advisers13,165$100K0.0%+15.0%0.041% 2/9/2021 Wells Fargo & Company MN18,084$138K0.0%+46.0%0.057% 2/9/2021 Bank of New York Mellon Corp55,827$427K0.0%+91.2%0.176% 2/5/2021BlackRock Inc.903,727$6.90M0.0%+25.5%2.843% 2/4/2021 State of Wisconsin Investment Board22,800$174K0.0%N/A0.072% 11/16/2020 Samlyn Capital LLC773,895$7.03M0.1%-1.7%2.435% 11/13/2020Jefferies Group LLC33,948$308K0.0%N/A0.107% 11/12/2020 JPMorgan Chase & Co.307,607$2.91M0.0%-12.0%0.968% 11/6/2020BlackRock Inc.719,959$6.54M0.0%+3.1%2.346% 10/30/2020 BNP Paribas Arbitrage SA3,239$29K0.0%+143.9%0.011% (Data available from 1/1/2016 forward) LOGC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LOGC shares? During the previous two years, the following institutional investors and hedge funds held shares of LogicBio Therapeutics shares: Barclays PLC ($252K).Learn more on LOGC's institutional investors. What percentage of LogicBio Therapeutics stock is owned by institutional investors? 46.05% of LogicBio Therapeutics stock is owned by institutional investors. Learn more on LOGC's institutional investor holdings. Which institutional investors have been buying LogicBio Therapeutics stock? The following institutional investors have purchased LogicBio Therapeutics stock in the last 24 months: Barclays PLC ($46.19K). How much institutional buying is happening at LogicBio Therapeutics? Institutional investors have bought a total of 46,190 shares in the last 24 months. This purchase volume represents approximately $251.74K in transactions. Related Companies Editas Medicine Major Shareholders uniQure Major Shareholders Voyager Therapeutics Major Shareholders Sangamo Therapeutics Major Shareholders MYT Netherlands Parent B.V. Major Shareholders Stitch Fix Major Shareholders Beyond Major Shareholders ThredUp Major Shareholders Qurate Retail Major Shareholders 1stdibs.Com Major Shareholders This page (NASDAQ:LOGC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
